DermTech, Inc. (DMTKQ)
OTCMKTS: DMTKQ · Delayed Price · USD
0.0612
-0.0088 (-12.57%)
Jul 22, 2024, 9:50 AM EDT - Market open
DermTech Revenue
DermTech had revenue of $15.66M in the twelve months ending March 31, 2024, with 9.71% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.85M with 10.58% year-over-year growth. In the year 2023, DermTech had annual revenue of $15.30M with 5.36% growth.
Revenue (ttm)
$15.66M
Revenue Growth
+9.71%
P/S Ratio
0.16
Revenue / Employee
$75,308
Employees
208
Market Cap
2.14M
Revenue Chart
* The company reports in USD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 15.30M | 778.00K | 5.36% |
Dec 31, 2022 | 14.52M | 2.68M | 22.64% |
Dec 31, 2021 | 11.84M | 5.95M | 101.16% |
Dec 31, 2020 | 5.89M | 2.52M | 74.94% |
Dec 31, 2019 | 3.36M | 922.00K | 37.76% |
Dec 31, 2018 | 2.44M | - | - |
Mar 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 48.86B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Eli Lilly | 35.93B |
DMTKQ News
- 4 weeks ago - Crude Oil Rises 1%; DermTech Shares Plummet - Benzinga
- 4 weeks ago - DermTech Files for Voluntary Chapter 11 Protection - Business Wire
- 2 months ago - DermTech Reports First-Quarter 2024 Financial Results - Business Wire
- 3 months ago - DermTech to Explore Strategic Alternatives and Implement Restructuring Plan - Business Wire
- 3 months ago - DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 months ago - DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology - Business Wire
- 5 months ago - DermTech Reports Fourth-Quarter 2023 Financial Results - Business Wire
- 5 months ago - DermTech Announces Release Date for Fourth-quarter 2023 Financial Results - Business Wire